Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

The effects of early allergen/endotoxin exposure on subsequent allergic airway inflammation to allergen in mouse model of asthma

생쥐 천식모델에서 생후 조기 알레르겐/내독소 노출이 성숙 후 알레르기 기도염증에 미치는 영향

  • Rha, Yeong-Ho (Departement of Pediatrics, School of Medicine, Kyunghee University) ;
  • Choi, Sun-Hee (Departement of Pediatrics, School of Medicine, Kyunghee University)
  • 나영호 (경희대학교 의과대학 소아과학교실) ;
  • 최선희 (경희대학교 의과대학 소아과학교실)
  • Received : 2010.01.05
  • Accepted : 2010.03.25
  • Published : 2010.04.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Recently many studies show early exposure during childhood growth to endotoxin (lipopolysaccharides, LPS) and/or early exposure to allergens exhibit important role in development of allergy including bronchial asthma. The aim of this study was to evaluate the role of endotoxin and allergen exposure in early life via the airways in the pathogenesis of allergic airways inflammation and airway hyperresposiveness (AHR) in mouse model of asthma. Methods: Less than one week-old Balb/c mice was used. Groups of mice were received either a single intranasal instillation of sterile physiologic saline, 1% ovalbumin (OVA), LPS or $1.0{\mu}g$ LPS in 1% OVA. On 35th day, these animals were sensitized with 1% OVA for 10 consecutive days via the airways. Animals were challenged with ovalbumin for 3 days on 55th days, and airway inflammation, hyperresponsiveness, and cytokine expression were assessed. Measurements of airway function were obtained in unrestrained animals, using whole-body plethysmography. Airway responsiveness was expressed in terms of % enhanced pause (Penh) increase from baseline to aerosolized methacholine. Lung eosinophilia, serum OVA-IgE and bronchoalveolar lavage (BAL) fluid cytokine levels were also assessed. ANOVA was used to determine the levels of difference between all groups. Comparisons for all pairs were performed by Tukey-Kramer honest significant difference test; $P$ values for significance were set to 0.05. Results: Sensitized and challenged mice with OVA showed significant airway eosinophilia and heightened responsiveness to methacholine. Early life exposure of OVA and/or LPS via the airway prevented both development of AHR as well as bronchoalveolar lavage fluid eosinophilia. Exposure with OVA or LPS also resulted in suppression of interleukin (IL)-4, 5 production in BAL fluid and OVA specific IgE in blood. Conclusion: These results indicate that antigen and/or LPS exposure in the early life results in inhibition of allergic responses to OVA in this mouse model of astham. Our data show that early life exposure with OVA and/or LPS may have a protective role in the development of allergic airway inflammation and development of allergen-induced airway responses in mouse model of asthma.

목 적: 최근 여러 연구결과 천식을 포함한 알레르기질환의 발병에 소아 성장시기에 알레르겐이나 내독소(LPS)등과 같은 물질에 노출이 중요한 역할을 하는 것으로 제시되었다. 이에 연구자들은 출생 초기에 기도 점막을 통한 알레르겐과 내독소에의 노출이 성장한 후에 알레르기 기도염증과 과반응성의 발생에 미치는 효과를 생쥐 모델을 통하여 규명하고자 본 연구를 시행하였다. 방 법: 실험동물은 무균 상태의 생후 1주이내의 암컷 BALB/c 생쥐를 사용하였다. 실험동물들에게는 각각 신생생쥐시기에 생리식염수, 1% ovalbumin (OVA), $1.0{\mu}g$ LPS, $1.0{\mu}g$ LPS in 1% OVA를 각 비공을 통하여 투여하였다. 실험동물은 연구 시작 제 35일부터 10일간 5% OVA로 감작시켰으며 최종 기도 감작 10일 후부터 3일간 1% OVA로 기도 항원유발을 시행하였다. 최종 기도유발 48시간 후 체적검사(plethysmography)를 이용하여 비특이적 기도과반응성 검사(Methcholine challenge test)를 시행하였으며 검사 후 실험동물을 희생시켜 검체를 취하여 BAL액내 세포분획, 사이토카인, 혈청 면역글로불린을 측정하였다. 결 과: 1) 메타콜린에 의한 기도과반응성은 생후 초기에 OVA, LPS, OVA/LPS를 투여한 군에서 생리식염수를 투여한 군에 비해 통계적으로 유의하게 억제되었다. 2) OVA, LPS, OVA/LPS를 투여한 군에서 BAL 액내의 호산구수와 IL-4, IL-5가 유의하게 낮았다. 3) 혈청내 OVA 특이 IgE는 OVA, LPS, OVA/LPS 투여군에서 유의하게 감소되었다. 결 론: 본 연구 결과 신생생쥐 시기의 점막을 통한 항원, 내독소의 노출이 성숙한 후 항원에 의한 기도염증 및 과반응성의 발생을 억제하였으며 향후 이러한 효과의 작용기전에 대한 연구가 필요할 것으로 생각한다.

Keywords

References

  1. Reidler J, Braun-Fahrlander C, Eder W, Schreuer M, Waser M, Maisch S, et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 2001;358:1129-33. https://doi.org/10.1016/S0140-6736(01)06252-3
  2. Levesque B, Rhainds M, Ernst P, Gernier AM, Kosatsky T, Audet N, et al. Asthma and allergic rhinitis in Quebec children. Can Respir J 2004;11:343-8.
  3. Braun-Fahrlander C, Gassner M, Grize L, Neu U, Sennhauser FH, Varonier HS, et al. Prevalence of hay fever and allergic sensitization in farmer's children and their peers living in the same rural community. SCARPOL team. Swiss Study on Childhood Allergy and Respiratory Symptoms With Respect to Air Pollution. Clin Exp Allergy 1999;29:28-34. https://doi.org/10.1046/j.1365-2222.1999.00479.x
  4. Kilpelainen M, Terho EO, Helenius H, Koskenvuo M. Childhood farm environment and asthma and sensitization in young adulthood. Allergy 2002;57:1130-5. https://doi.org/10.1034/j.1398-9995.2002.23341.x
  5. Ernst P, Cormier Y. Relative scarcity of asthma and atopy among rural adolescents raised on a farm. Am J Respir Crit Care Med 2000;161:1563-6. https://doi.org/10.1164/ajrccm.161.5.9908119
  6. von Mutius E, Braun-Fahrlander E, Schierl R, Riedler J, Ehlermann S, Maisch S, et al. Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy 2000;30:1230-4. https://doi.org/10.1046/j.1365-2222.2000.00959.x
  7. von Mutius E. Influences in allergy: epidemiology and the environment. J Allergy Clin Immunol 2004;113:373-9.
  8. Braun-Fahrlander C, Riedler J, Herz U, Eder W, Waser M, Grize L,et al. Allergy and Endotoxin Study Team. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002;347:869-77. https://doi.org/10.1056/NEJMoa020057
  9. Roponen M, Hyvarinen A, Hirvonen MR, Keski-Nisula L, Pekkanen J. Change in IFN-gamma-producing capacity in early life and exposure to environmental microbes. J Allergy Clin Immunol 2005;116:1048-52. https://doi.org/10.1016/j.jaci.2005.08.039
  10. Akbari O, Stock P, DeKruyff RH, Umetsu DT, Mucosal tolerance and immunity: regulating the development of allergic disease and asthma. Int Arch Allergy Immunol 2003; 130:108-18. https://doi.org/10.1159/000069012
  11. Gentile DA, Schreiber R, Howe-Adams J, Trecki J, Patel A, Angelini B, et al. Diminished dendritic cell interleukin 10 production in atopic children. Ann Allergy Asthma Immunol 2004;92:538-44. https://doi.org/10.1016/S1081-1206(10)61761-9
  12. Samsom JN, van Berkel LA, van Helvoort JM, Unger WW, Jansen W, Thepen T, et al. Fc gamma RIIB regulates nasal and oral tolerance: a role for dendritic cells. J Immunol 2005;174:5279-87.
  13. Jaffar Z, Sivakuru T, Roberts K. CD4+CD25+ T cells regulate airway eosinophilic inflammation by modulating the Th2 cell phenotype. J Immunol 2004;172:3842-49.
  14. Amoudruz P, Holmlund U, Malmstrom V, Trollmo C, Bremme K, Scheynius A, et al. Neonatal immune responses to microbial stimuli: is there an influence of maternal allergy? J Allergy Clin Immunol 2005;115:1304-10. https://doi.org/10.1016/j.jaci.2005.02.036
  15. Hoffjan S, Ostrovnaja I, Nicolae D, Newman DL, Nicolae R, Gangnon R, et al. Genetic variation in immunoregulatory pathways and atopic phenotypes in infancy. J Allergy Clin Immunol 2004:113:511-8. https://doi.org/10.1016/j.jaci.2003.10.044
  16. Hoffjan S, Nicolae D, Ostrovnaya I, Roberg K, Evans M, Mirel DB, et al.. Gene-environment interaction effects on the development of immune responses in the 1st year of life. Am J Hum Genet 2005:76:696-704. https://doi.org/10.1086/429418
  17. Prescott SL, Taylor A, Roper J, Wahdan A, Noakes P, Thornton C, et al. Maternal reactivity to fetal alloantigens is related to newborn immune responses and subsequent allergic disease. Clin Exp Allergy 2005;35:417-25. https://doi.org/10.1111/j.1365-2222.2005.02171.x
  18. Celedon JC, Litonjua AA, Ryan L, Platts-Mills T, Weiss ST, Gold DR. Exposure to cat allergen, maternal history of asthma, and wheezing in first 5 years of life. Lancet 2002; 360:781-82. https://doi.org/10.1016/S0140-6736(02)09906-3
  19. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989;299:1259-60. https://doi.org/10.1136/bmj.299.6710.1259
  20. Liu AH. Endotoxin exposure in allergy and asthma: reconciling a paradox. J Allergy Clin Immunol 2002;109:379-92. https://doi.org/10.1067/mai.2002.122157
  21. Stock P, Akbari O, Berry G, Freeman GJ, Dekruyff RH, Umetsu DT. Inducton of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol 2004;5:1149-56. https://doi.org/10.1038/ni1122
  22. Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology 2004;112:352- 63. https://doi.org/10.1111/j.1365-2567.2004.01925.x
  23. Adkins B, Bu Y, Guevara P. Murine neonatal CD4+ lymph node cells are highly deficient in the development of antigenspecific Th1 function in adoptive adult hosts. J Immunol 2002;169:4998-5004.
  24. Douwes J, Le Gros G, Gibson P, Pearce N. Can bacterial endotoxin exposure reverse atopy and atopic disease? J Allergy Clin Immunol 2004;114:1051-4. https://doi.org/10.1016/j.jaci.2004.08.004
  25. Riedl MA, Landaw EM, Saxon A, Diaz-Sanchez D. Initial high-dose nasal allergen exposure prevents allergic sensitization to a neoantigen. J Immunol 2005;174:7440-5.
  26. Michel O, Duchateau J, Sergysels P. Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. J Appl Physiol 1989;66:1059-64.
  27. Dankesreiter S, Hoess A, Schneider-Mergener J, Wagner H, Miethke T. Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-$\alpha$ production by macrophages in vitro and in vivo and prevent endotoxin mediated toxic shock. J Immunol 2000;164:4804-11.
  28. Kotanidou A, Xagorari A, Bagli E, Kitsanta P, Fotsis T, Papapetropoulos A, et al. Luteolin reduces lipopolysaccharideinduced lethal toxicity and expression of proinflammatory molecules in mice. Am J Respir Crit Care Med 2002;165: 818-23. https://doi.org/10.1164/ajrccm.165.6.2101049
  29. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999;11:115-22. https://doi.org/10.1016/S1074-7613(00)80086-2
  30. Zeldin DC, Wohlford-Lenane C, Chulada P, Alyce Bradbury J, Scarborough PE, Roggli V, et al. Airway inflammation and responsiveness in prostaglandin H synthase-deficient mice exposed to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 2001;25:457-65. https://doi.org/10.1165/ajrcmb.25.4.4505
  31. Delayre-Orthez C, Becker J, de Blay F, Frossard N, Pons f. Exposure to endotoxins during sensitization prevents further endotoxin-induced exacerbation of airway inflammation in a mouse model of allergic asthma. Int Arch Allergy Immunol 2005;138:298-304. https://doi.org/10.1159/000088867
  32. Hawrylowicz CM, O'Garra A. Potential role of interleukin- 10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005;5:271-83. https://doi.org/10.1038/nri1589
  33. Oh JW, Seroogy CM, Meyer EH, Akbari O, Berry G, Fathman CG, et al. CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. J Allergy Clin Immunol 2002;110:460-8. https://doi.org/10.1067/mai.2002.127512
  34. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001;2:725-31. https://doi.org/10.1038/90667
  35. Matsumoto K, Inoue H, Tsuda M, Honda Y, Kibe A, Machida K, et al. Different roles of interleukin-10 in onset and resolution of asthmatic responses in allergen-challenged mice. Respirology 2005;10:18-26. https://doi.org/10.1111/j.1440-1843.2005.00647.x
  36. Eisenbarth SC, Zhadkevich A, Ranney P, Herrick CA, Bottomly ,K. Understanding asthma pathogenesis: linking innate and adaptive immunity. Curr Opin Pediatr 2004;16: 659-66. https://doi.org/10.1097/01.mop.0000145920.00101.e4
  37. Blumer N, Herz U, Wegmann M, Renz H. Prenatal lipopolysaccharide -exposure prevents allergic sensitization and airway inflammation, but not airway responsiveness in a murine model of experimental asthma. Clin Exp Allergy 2005; 35:397-402. https://doi.org/10.1111/j.1365-2222.2005.02184.x
  38. Tulic MK, Wale JL, Holt PG, Sly PD. Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 2000; 22:604-12. https://doi.org/10.1165/ajrcmb.22.5.3710
  39. Tulic MK, Holt PG, Sly PD. Modification of acute and late-phase allergic responses to ovalbumin with lipopolysaccharide. Int Arch Allergy Immunol 2002;129:119-28. https://doi.org/10.1159/000065881
  40. Tulic MK, Fiset PO, Manoukian JJ, Frenkiel S, Lavigne F, Eidelman DH, et al. Role of toll-like receptor 4 in protection by bacterial lipopolysaccharide in the nasal mucosa of atopic children but not adults. Lancet 2004;363:1689-97. https://doi.org/10.1016/S0140-6736(04)16253-3
  41. Holt PG, Macaubas C, Stumbles PA, Sly PD. The role of allergy in the development of asthma, Nature 1999;402:B12-7.
  42. Gereda JE, Leung DYM, Thatayatikom A. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitization in infants at high risk of asthma. Lancet 2000;355:1680-3. https://doi.org/10.1016/S0140-6736(00)02239-X
  43. Illi S, von Mutius E, Lau S, et al. Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. BMJ 2001;322:390-5. https://doi.org/10.1136/bmj.322.7283.390